<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: gsk</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>Elan enters $1B royalty deal with Theravance</title>
   	 <description>Irish drugmaker Elan Corp. PLC plans to pay $1 billion for the right to future royalties from four respiratory treatments being developed by Theravance Inc. and GlaxoSmithKline.</description>
     <link>http://medicalxpress.com/news/2013-05-irish-biotech-firm-elan-bn.html</link>
	 <category>Medications</category>
	 <pubDate>Mon, 13 May 2013 08:00:09 EST</pubDate>
	 <guid isPermaLink="false">news287650801</guid>
	 
</item>
<item>
     <title>Save the Children teams up with pharma giant GSK in Africa</title>
   	 <description>International development charity Save the Children is linking up with British pharmaceutical giant GlaxoSmithKline in what both sides say is a unique collaboration to save children's lives in Africa.</description>
     <link>http://medicalxpress.com/news/2013-05-children-teams-pharma-giant-gsk.html</link>
	 <category>Medications</category>
	 <pubDate>Fri, 10 May 2013 14:10:02 EST</pubDate>
	 <guid isPermaLink="false">news287412491</guid>
	 
</item>
<item>
     <title>Drugmaker GSK posts slumping Q1 profits</title>
   	 <description>British drugs firm GlaxoSmithKline on Wednesday said its first-quarter net profit tumbled by almost a third, with the group hit by falling sales and a poor economic climate.</description>
     <link>http://medicalxpress.com/news/2013-04-drugmaker-gsk-slumping-q1-profits.html</link>
	 <category>Medications</category>
	 <pubDate>Wed, 24 Apr 2013 12:00:06 EST</pubDate>
	 <guid isPermaLink="false">news286022544</guid>
	 
</item>
<item>
     <title>UK alleges GSK paid off competitors to delay drugs</title>
   	 <description>Britain's competition watchdog accused GlaxoSmithKline on Friday of paying off competitors to delay launches of their own versions of GSK's best-selling antidepressant, Seroxat.</description>
     <link>http://medicalxpress.com/news/2013-04-uk-alleges-gsk-paid-competitors.html</link>
	 <category>Medications</category>
	 <pubDate>Fri, 19 Apr 2013 11:51:59 EST</pubDate>
	 <guid isPermaLink="false">news285591110</guid>
	 
</item>
<item>
     <title>Drugmaker GSK reveals lower profits, restructuring</title>
   	 <description>British drugs firm GlaxoSmithKline on Wednesday unveiled a 13-percent drop in annual net profits and outlined a plan for more restructuring in Europe to deliver greater savings and offset weaker sales across the region.</description>
     <link>http://medicalxpress.com/news/2013-02-glaxosmithkline-full-year-net-profits.html</link>
	 <category>Other</category>
	 <pubDate>Wed, 06 Feb 2013 12:10:01 EST</pubDate>
	 <guid isPermaLink="false">news279373344</guid>
	 
</item>
<item>
     <title>Major step toward an Alzheimer's vaccine</title>
   	 <description>A team of researchers from Université Laval, CHU de Québec, and pharmaceutical firm GlaxoSmithKline (GSK) has discovered a way to stimulate the brain's natural defense mechanisms in people with Alzheimer's disease. This major breakthrough, details of which are presented today in an early online edition of the Proceedings of the National Academy of Sciences (PNAS), opens the door to the development of a treatment for Alzheimer's disease and a vaccine to prevent the illness.</description>
     <link>http://medicalxpress.com/news/2013-01-major-alzheimer-vaccine.html</link>
	 <category>Alzheimer's disease &amp; dementia</category>
	 <pubDate>Tue, 15 Jan 2013 12:49:36 EST</pubDate>
	 <guid isPermaLink="false">news277476510</guid>
	 
</item>
<item>
     <title>Study identifies key cellular mechanisms behind the onset of tinnitus</title>
   	 <description>Researchers in the University of Leicester's Department of Cell Physiology and Pharmacology have identified a cellular mechanism that could underlie the development of tinnitus following exposure to loud noises. The discovery could lead to novel tinnitus treatments, and investigations into potential drugs to prevent tinnitus are currently underway.</description>
     <link>http://medicalxpress.com/news/2012-05-key-cellular-mechanisms-onset-tinnitus.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Thu, 10 May 2012 10:31:12 EST</pubDate>
	 <guid isPermaLink="false">news255864662</guid>
	 
</item>
<item>
     <title>GSK launches hostile $2.6 bn bid for Human Genome Sciences</title>
   	 <description> British drugmaker GlaxoSmithKline on Wednesday said it had gone hostile over its $2.6 billion (2.0 billion-euro) takeover bid for US research partner Human Genome Sciences Inc. </description>
     <link>http://medicalxpress.com/news/2012-05-gsk-hostile-bn-human-genome.html</link>
	 <category>Medications</category>
	 <pubDate>Wed, 09 May 2012 07:38:40 EST</pubDate>
	 <guid isPermaLink="false">news255767913</guid>
	 
</item>
<item>
     <title>Glaxo sells key European brands to Belgium's Omega Pharma</title>
   	 <description> British drugmaker GlaxoSmithKline said Thursday that it would sell a stable of well-known European over-the-counter brands, including Nytol sleep aid, to Belgium's Omega Pharma.</description>
     <link>http://medicalxpress.com/news/2012-03-glaxo-key-european-brands-belgium.html</link>
	 <category>Other</category>
	 <pubDate>Thu, 15 Mar 2012 08:41:44 EST</pubDate>
	 <guid isPermaLink="false">news251019698</guid>
	 
</item>
<item>
     <title>British drugs firm GSK settles US drug disputes for $3.0 bln</title>
   	 <description> GlaxoSmithKline said on Thursday it had agreed to pay $3.0 billion (2.2 billion euros) to settle long-running disputes with the US government over how the British pharmaceuticals group marketed and developed drugs.</description>
     <link>http://medicalxpress.com/news/2011-11-british-drugs-firm-gsk-drug.html</link>
	 <category>Medications</category>
	 <pubDate>Thu, 03 Nov 2011 08:37:10 EST</pubDate>
	 <guid isPermaLink="false">news239528214</guid>
	 
</item>
<item>
     <title>Drug firm GSK fined $2.6 million for collusion</title>
   	 <description> South Korea's anti-trust agency has fined drugmaker GlaxoSmithKline three billion won ($2.6 million) for conspiring with a Seoul rival over the sale of drugs, an official said Monday. </description>
     <link>http://medicalxpress.com/news/2011-10-drug-firm-gsk-fined-million.html</link>
	 <category>Medications</category>
	 <pubDate>Mon, 24 Oct 2011 04:33:14 EST</pubDate>
	 <guid isPermaLink="false">news238649580</guid>
	 
</item>


</channel>
</rss>
